Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Koichi Shibutani is active.

Publication


Featured researches published by Koichi Shibutani.


Hepatology Research | 2016

Temporal variations in stump pressure and assessment of images obtained from cone‐beam computed tomography during balloon‐occluded transarterial chemoembolization

Akihisa Kakuta; Koichi Shibutani; Shuichi Ono; Hiroyuki Miura; Fumiyasu Tsushima; Shinya Kakehata; Kiyoshi Basaki; Hiromasa Fujita; Hiroko Seino; Tamaki Fujita; Yoshihiro Takai

Balloon‐occluded transcatheter arterial chemoembolization (B‐TACE) was used to show the optimized duration of balloon occlusion to start injection of lipiodol in order to maximize lipiodol deposition in the nodule, and to reveal the endpoint of lipiodol injection.


Cancer Chemotherapy and Pharmacology | 1994

Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE)

Hiraku Yodono; Shoichi Takekawa; Koji Tarusawa; Isao Ikami; Jiro Kanehira; Yoko Saito; Satoshi Takahashi; Taisuke Sasaki; Naoko Nishi; Tamaki Kimura; Shigeo Oikawa; Koichi Shibutani; Atsushi Shinohara; Akira Anbai; Rikako Sasaki; Yukio Sasaki; Hiroshi Noda

From January 1988 to January 1993, 45 patients with unresectable advanced hepatocellular carcinoma (HCC) were treated with a new combination therapy consisting of arterial infusion chemotherapy and TAE. The combination therapy was performed according to our treatment schedule as follows: two courses of arterial infusion chemotherapy were given first, and then transcatheter arterial embolization (TAE) using a mixture of Lipiodol and cisplatin powder was performed. Two arterial infusion chemotherapeutic regimens were employed: EPF (etoposide, cisplatin, and 5-fluorouracil) and EAP (etoposide, Adriamycin or Epi-adriamycin, and cisplatin). The anticancer drugs were infused through a catheter inserted into the proper or common hepatic artery. Assessment was made of the anticancer effect and survival rate of each treatment method. The response to each therapy was evaluated on the basis of CT performed prior to and after the treatment. In the EPF·TAE group, the response rate was about 46%, whereas in the EAP·TAE group it was 48%. Overall, 21 of 45 patients attained a regression rate of 50% or more. Furthermore, daughter nodules decreased in size or disappeared in about 67% of 15 patients. Additionally, tumor thrombi tended to show a similar response. In all of the cases, the average duration of survival was 30.3 months, and the 1-year survival value was 68%, the 2-year survival value was 44%, and the 3-year survival value was 35%. These results were superior to those obtained with TAE therapy alone.


SpringerPlus | 2014

Contribution of dynamic sentinel lymphoscintigraphy images to the diagnosis of patients with malignant skin neoplasms in the upper and lower extremities

Hiroyuki Miura; Shuichi Ono; Koichi Shibutani; Hiroko Seino; Fumiyasu Tsushima; Shinya Kakehata; Katsumi Hirose; Hiromasa Fujita; Akihisa Kakuta; Masahiko Aoki; Yoshiomi Hatayma; Hideo Kawaguchi; Mariko Sato; Yoshihiro Takai; Takahide Kaneko; Daisuke Sawamura

The aim of the present study was to confirm the contribution of dynamic images in sentinel lymphoscintigraphy in malignant skin neoplasms: precisely, to investigate if dynamic images were necessary and to observe if dynamic images could reduce the areas needed for biopsy and dissection. Twenty-five patients with malignant skin neoplasms of the lower (n = 21) and upper (n = 4) extremities were retrospectively investigated. Images were evaluated by two independent reviewers, an expert in diagnostic radiology and nuclear medicine and a diagnostic radiologist in training. Visualized hot spots were assessed to be sentinel nodes using only static planar images. Next, both static planar and dynamic images were assessed. Reviewers scored diagnostic confidence values of determined sentinel nodes as follows: 0, cannot be decided; 1, possible; 2, probable; and 3, definitive. Patterns of lymphatic drainage were categorized into six different pathways: (1) inguinal type, (2) popliteal type, (3) inguinal and popliteal type, (4) axillary type, (5) cubital type, and (6) axillary and cubital type. In cases in the lower extremities, with dynamic images, the expert reviewer changed assessment in three cases and the trainee reviewer changed it in one case. There were no cases in which a decision was changed to be the same between both reviewers. Although the average diagnostic confidence value of assessment is usually higher with dynamic images, significant differences were not present. In cases of the upper extremities, both reviewers changed their assessment in one patient. By mutual agreement, cases in which assessment was changed with dynamic images were the inguinal and popliteal type, and the axillary and cubital type. The expert reviewer noticed lymphatic channels only visualized on dynamic images and changed assessment. Determination of whether or not a lymph node is a sentinel node depends on visualization of the lymphatic network. In the present circumstances, all biopsies of hot spots determined to be lymph nodes should not be excluded. However, excessive biopsies should be avoided as much as possible. It is necessary to use dynamic images alongside skillful observation.


Journal of General and Family Medicine | 2015

Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients 20 Years after Achieving a Sustained Virological Response with Interferon Therapy: A Report of Two Cases

Go Igarashi; Tetsu Endo; Naoya Sawada; Kenichiro Mikami; Ken Sato; Daisuke Kudo; Yoshikazu Toyoki; Kenichi Hakamada; Akihisa Kakuta; Koichi Shibutani; Yoshihiro Takai; Tadashi Yoshizawa; Toshihiro Haga; Hiroshi Kijima; Shinsaku Fukuda

Advances in interferon (IFN)‐based therapy for chronic hepatitis C have led to a high rate of sustained virological response (SVR), which means viral clearance. However, some cases have been reported to develop hepatocellular carcinoma (HCC) over 10 years after achieving the SVR. Here, we report two patients who developed HCC 20 years after SVR with IFN therapy. Both of the patients were male and achieved SVR at the age of 46 years and 61 years, respectively. These cases suggest the need for long‐term follow‐up in patients with chronic hepatitis C even if SVR is achieved.


Digestion | 2014

Prediction of Maintained Mucosal Healing in Patients with Crohn's Disease under Treatment with Infliximab Using Diffusion-Weighted Magnetic Resonance Imaging

Hirotake Sakuraba; Yoh Ishiguro; Keisuke Hasui; Hiroto Hiraga; Shinsaku Fukuda; Koichi Shibutani; Yoshihiro Takai


Internal Medicine | 2014

A successful case of transcatheter arterial embolization with n-butyl-2-cyanoacrylate for pancreatic arteriovenous malformation.

Tetsuya Tatsuta; Tetsu Endo; Kiyotaka Watanabe; Keisuke Hasui; Naoya Sawada; Go Igarashi; Kenichiro Mikami; Koichi Shibutani; Fumiyasu Tsushima; Yoshihiro Takai; Shinsaku Fukuda


Annals of Nuclear Medicine | 2010

Lymphoscintigraphy for sentinel lymph node mapping in Japanese patients with malignant skin neoplasms of the lower extremities: comparison with previously investigated Japanese lymphatic anatomy.

Hiroyuki Miura; Shuichi Ono; Morio Nagahata; Koichi Shibutani; Shinya Kakehata; Kohei Morimoto; Hiroko Seino; Akihisa Kakuta; Masahiko Aoki; Yoshiomi Hatayama; Hideo Kawaguchi; Yoshihiro Takai; Yoshinao Abe; Takahide Kaneko; Daisuke Sawamura; Katsumi Hanada


Digestion | 2014

IGICS: JGA Keynote Program. The 6th International Gastrointestinal Consensus Symposium. Microbiomes in Gastrointestinal Disease. January 26, 2013, Tokyo, Japan: Abstracts

Hiromu Suzuki; Yasutaka Sukawa; H. Inoue; Y. Akazawa; Katsuhiko Nosho; H. Minami; Yasuhisa Shinomura; Miki Ito; H. Isomoto; Hisayoshi Igarashi; Yasutaka Matsunaga; Taiga Takahashi; Genki Mori; Naoki Horikawa; Kazuhisa Yabuhita; Toshiro Sugiyama; Shiro Nakamura; Gakuto Tomizawa; Yasuyuki Okada; Hiroshi Miyamoto; K. Ohnita; Masashi Mikami; Yasushi Adachi; Eiko Saito; Hiroyuki Yamamoto; Taku Sakamoto; Chiko Sato; N. Yamaguchi; Izumi Kaji; Shin-ichiro Karaki


弘前医学 | 2013

Efficacy and Safety of Preoperative Portal Vein Embolization with Microfibrillar Collagen for Hepatobiliary Malignancy

Koichi Shibutani; Fumiyasu Tsushima; Shinya Kakehata; Hiroyuki Miura; Shuichi Ono; Hiroko Seino; Akihisa Kakuta; Toshihide Tokuda; Yoshikazu Toyoki; Kenichi Hakamada; Yoshihiro Takai


Archive | 2013

A Case of Acute Heart Failure With Intravenous Acetazolamide Administration for Evaluation of

Hiroyuki Miura; Shuichi Ono; Koichi Shibutani; Shinya Kakehata; Hiroko Seino; Fumiyasu Tsushima; Akihisa Kakuta; Hiromasa Fujita; Yoshihiro Takai

Collaboration


Dive into the Koichi Shibutani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge